Nkarta Reports First Quarter 2023 Financial Results and

Clinical updates on track for NKX101 in second quarter of 2023 at a company-hosted event and NKX019 in second half of 2023Cash and cash equivalents of...

Related Keywords

United States ,American ,Greg Mann ,Paulj Hastings ,International Conference On Malignant Lymphoma ,Exchange Commission ,Clinical Program Updates ,Nasdaq ,American Association Of Cancer Research ,Nkarta Inc ,European Hematology Association ,International Conference ,Malignant Lymphoma ,Cancer Research ,Nadir Mahmood ,Recent Financial ,Cash Equivalents ,Private Securities Litigation Reform Act ,Annual Report ,Months Ended March ,Investor Contact ,Nasdaq Nktx ,Jakarta ,Nc ,